CLARIVATE executive awarded 377,358 new shares

CLARIVATE PLC President, A&G Bar Veinstein received a large equity award.

Rhea-AI Filing Summary

CLARIVATE PLC President, A&G Bar Veinstein received a large equity award. He was granted 377,358 Ordinary Shares on a non-cash basis, classified as a grant or award acquisition. This compensation-related grant increased his direct holdings to 1,263,016 Ordinary Shares, aligning more of his pay with the company’s share performance.

Insights

Equity compensation analyst

Large stock grant increases executive’s equity stake but is not a market trade.

Bar Veinstein, President, A&G at CLARIVATE PLC, received 377,358 Ordinary Shares as a grant with a reported price of $0.0000 per share. This indicates a compensation award rather than an open-market purchase.

The grant lifts his directly held position to 1,263,016 Ordinary Shares. Because this is not a cash transaction and involves no sale, it mainly strengthens equity-based incentives instead of signaling a view on the current share price.

As a standard Form 4 compensation entry with no accompanying sales, this event is typically viewed as routine from a market-sentiment standpoint, though it does increase management’s exposure to future share performance.

Insider Trade Summary

Grant/Award: 377,358 shares

Grant/Award 1 txn

Insider Veinstein Bar

Role President, A&G

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	377,358	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 1,263,016 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CLVT executive Bar Veinstein report in this Form 4 filing?

Bar Veinstein reported receiving a grant of 377,358 CLARIVATE PLC Ordinary Shares. The award was recorded at a price of $0.0000 per share, indicating a compensation-related grant rather than an open-market purchase, and increased his directly held position.

How many CLVT shares does Bar Veinstein hold after this reported grant?

After the grant, Bar Veinstein directly holds 1,263,016 CLARIVATE PLC Ordinary Shares. This figure reflects his ownership immediately following the 377,358-share award and highlights the scale of his equity stake in the company after the compensation event.

Was the CLVT insider transaction a market buy or a compensation grant?

The transaction was a compensation grant, not a market buy. The Form 4 classifies it as a grant, award, or other acquisition, with a transaction price of $0.0000 per share, which is typical for equity awards granted as part of executive compensation packages.

Does this CLVT Form 4 filing show any insider share sales?

No insider sales are reported in this Form 4. The filing discloses only an acquisition of 377,358 Ordinary Shares as a grant. The transaction summary shows one acquisition and no dispositions, emphasizing this is an award, not a sale or exercise-and-sell sequence.

What role does Bar Veinstein hold at CLVT related to this Form 4?

Bar Veinstein is identified as President, A&G at CLARIVATE PLC. His position as a senior officer requires reporting changes in beneficial ownership, so this 377,358-share grant and the resulting 1,263,016 directly held shares are disclosed through the Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 06:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Veinstein Bar

(Last) (First) (Middle)

C/O CLARIVATE PLC

70 ST MARY AXE

(Street)

LONDON X0 EC3A 8BE

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLARIVATE PLC [ CLVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, A&G

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/15/2026		A		377,358	A	$0	1,263,016	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ John Doulamis, Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.